Articles Tagged With:
-
Does a Gluten-free Diet Lower the Risk of Coronary Artery Disease in Adults?
A prospective, cohort study of health professionals conducted over 24 years revealed no significant association between long-term consumption of gluten and the risk of coronary artery disease in both adult men and women with no history of coronary artery disease.
-
Researchers Urge IRBs to Preserve Location Data
Faced with the sudden emergence of this latest aspect of the tech revolution, many in bioethics initially err on the side of location data eradication.
-
University’s Central IRB Was Built From the Ground Up
With 37 relying sites and nine active studies, all within 1.5 years since inception, the University of Miami’s new central IRB was a success.
-
Should Subjects Who Drop Out of Studies Receive Compensation?
On the issue of payment to research subjects, what should be done if people drop out of the study?
-
Balancing Incentive and Risk in Paying Subjects
The current dearth of data on incentives for research participation raises ethical issues in such areas as informed consent and potential exploitation of vulnerable populations.
-
As Clock Ticks Toward Common Rule Implementation, New Guidance Offers Help
The new Common Rule changes are complex, not always easy to interpret, and sometimes seem to add more burdens on IRBs — even as the overarching purpose is to reduce time spent on reviews.
-
Recent Advances in Sleep Medicine
This article reviews recently published research on sleep medicine. -
Primary Headaches: Look, Listen, and Diagnose Rather Than Image
SYNOPSIS: The diagnosis of primary headache disorders by a computerized and clinical paradigm can predict a baseline prevalence of intracranial abnormalities on brain imaging. Some historical “red flags” in children with headaches, including morning headaches and occipital pain, are not associated with increased intracranial abnormalities.
-
Cerebellar Atrophy May Contribute to Cognitive Impairment in FTD
In this cross-sectional study, researchers identified distinct patterns of cerebellar atrophy and its association with cognitive dysfunction in the frontotemporal dementia syndromes.
-
Ibudilast Shows Promise for the Treatment of Progressive MS
A Phase II trial of ibudilast in progressive multiple sclerosis demonstrated a decreased rate of brain atrophy when compared to placebo.